Titre : Artériopathies intracrâniennes

Artériopathies intracrâniennes : Questions médicales fréquentes

Termes MeSH sélectionnés :

Gene Expression Regulation
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Artériopathies intracrâniennes : Questions médicales les plus fréquentes", "headline": "Artériopathies intracrâniennes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Artériopathies intracrâniennes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-14", "dateModified": "2025-02-08", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Artériopathies intracrâniennes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Angiopathies intracrâniennes", "url": "https://questionsmedicales.fr/mesh/D002561", "about": { "@type": "MedicalCondition", "name": "Angiopathies intracrâniennes", "code": { "@type": "MedicalCode", "code": "D002561", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.253" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Artériopathies cérébrales", "alternateName": "Cerebral Arterial Diseases", "url": "https://questionsmedicales.fr/mesh/D002539", "about": { "@type": "MedicalCondition", "name": "Artériopathies cérébrales", "code": { "@type": "MedicalCode", "code": "D002539", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.253.560.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Maladie de Moya-Moya", "alternateName": "Moyamoya Disease", "url": "https://questionsmedicales.fr/mesh/D009072", "about": { "@type": "MedicalCondition", "name": "Maladie de Moya-Moya", "code": { "@type": "MedicalCode", "code": "D009072", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.253.560.200.737" } } } ] }, { "@type": "MedicalWebPage", "name": "Anévrysme intracrânien", "alternateName": "Intracranial Aneurysm", "url": "https://questionsmedicales.fr/mesh/D002532", "about": { "@type": "MedicalCondition", "name": "Anévrysme intracrânien", "code": { "@type": "MedicalCode", "code": "D002532", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.253.560.300" } } }, { "@type": "MedicalWebPage", "name": "Artériosclérose intracrânienne", "alternateName": "Intracranial Arteriosclerosis", "url": "https://questionsmedicales.fr/mesh/D002537", "about": { "@type": "MedicalCondition", "name": "Artériosclérose intracrânienne", "code": { "@type": "MedicalCode", "code": "D002537", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C14.907.253.560.350" } } } ], "about": { "@type": "MedicalCondition", "name": "Artériopathies intracrâniennes", "alternateName": "Intracranial Arterial Diseases", "code": { "@type": "MedicalCode", "code": "D020765", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Xunming Ji", "url": "https://questionsmedicales.fr/author/Xunming%20Ji", "affiliation": { "@type": "Organization", "name": "8Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China." } }, { "@type": "Person", "name": "Pim A de Jong", "url": "https://questionsmedicales.fr/author/Pim%20A%20de%20Jong", "affiliation": { "@type": "Organization", "name": "Department of Radiology, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands." } }, { "@type": "Person", "name": "David S Liebeskind", "url": "https://questionsmedicales.fr/author/David%20S%20Liebeskind", "affiliation": { "@type": "Organization", "name": "UCLA Comprehensive Stroke Center, Department of Neurology, University of California, Los Angeles, CA, USA." } }, { "@type": "Person", "name": "Bo Song", "url": "https://questionsmedicales.fr/author/Bo%20Song", "affiliation": { "@type": "Organization", "name": "Department of Neurology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China." } }, { "@type": "Person", "name": "Thomas W Leung", "url": "https://questionsmedicales.fr/author/Thomas%20W%20Leung", "affiliation": { "@type": "Organization", "name": "Department of Medicine & Therapeutics, the Chinese University of Hong Kong, Hong Kong SAR, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Knockdown of SMYD3 by RNA Interference Regulates the Expression of Autophagy-Related Proteins and Inhibits Bone Formation in Fluoride-Exposed Osteoblasts.", "datePublished": "2024-08-06", "url": "https://questionsmedicales.fr/article/39106008", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s12011-024-04327-w" } }, { "@type": "ScholarlyArticle", "name": "Down-regulated expression of TIPE3 inhibits malignant progression of non-small cell lung cancer via Wnt signaling.", "datePublished": "2024-05-15", "url": "https://questionsmedicales.fr/article/38759744", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.yexcr.2024.114093" } }, { "@type": "ScholarlyArticle", "name": "TLR2-ERK signaling pathway regulates expression of galectin-3 in a murine model of OVA-induced allergic airway inflammation.", "datePublished": "2024-05-14", "url": "https://questionsmedicales.fr/article/38754639", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.toxlet.2024.05.008" } }, { "@type": "ScholarlyArticle", "name": "Circular RNA circVmn2r1 acts as a miR-223-3p sponge to promote kidney aging by regulating NLRP3 expression in mice.", "datePublished": "2024-03-06", "url": "https://questionsmedicales.fr/article/38447057", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1093/gerona/glae067" } }, { "@type": "ScholarlyArticle", "name": "CFL1 restores the migratory capacity of bone marrow mesenchymal stem cells in primary Sjögren's syndrome by regulating CCR1 expression.", "datePublished": "2024-01-05", "url": "https://questionsmedicales.fr/article/38183912", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.intimp.2024.111485" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies cardiovasculaires", "item": "https://questionsmedicales.fr/mesh/D002318" }, { "@type": "ListItem", "position": 3, "name": "Maladies vasculaires", "item": "https://questionsmedicales.fr/mesh/D014652" }, { "@type": "ListItem", "position": 4, "name": "Angiopathies intracrâniennes", "item": "https://questionsmedicales.fr/mesh/D002561" }, { "@type": "ListItem", "position": 5, "name": "Artériopathies intracrâniennes", "item": "https://questionsmedicales.fr/mesh/D020765" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Artériopathies intracrâniennes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Artériopathies intracrâniennes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Artériopathies intracrâniennes", "description": "Comment diagnostiquer une artériopathie intracrânienne ?\nQuels tests sont utilisés pour évaluer le flux sanguin cérébral ?\nQuels signes cliniques indiquent une artériopathie ?\nQuelle est l'importance des antécédents médicaux ?\nComment les tests sanguins aident-ils au diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D020765?mesh_terms=Gene+Expression+Regulation&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Artériopathies intracrâniennes", "description": "Quels sont les symptômes courants des artériopathies intracrâniennes ?\nComment reconnaître un AVC lié à une artériopathie ?\nLes symptômes peuvent-ils varier selon l'âge ?\nLes symptômes sont-ils toujours présents ?\nQuels symptômes nécessitent une consultation urgente ?", "url": "https://questionsmedicales.fr/mesh/D020765?mesh_terms=Gene+Expression+Regulation&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Artériopathies intracrâniennes", "description": "Comment prévenir les artériopathies intracrâniennes ?\nQuel rôle joue l'alimentation dans la prévention ?\nL'exercice physique est-il bénéfique ?\nComment le contrôle du stress aide-t-il ?\nLes bilans de santé réguliers sont-ils importants ?", "url": "https://questionsmedicales.fr/mesh/D020765?mesh_terms=Gene+Expression+Regulation&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Artériopathies intracrâniennes", "description": "Quels traitements sont disponibles pour les artériopathies ?\nComment les médicaments aident-ils dans le traitement ?\nQuand une intervention chirurgicale est-elle nécessaire ?\nLes traitements sont-ils différents pour les jeunes et les vieux ?\nQuel rôle joue la rééducation après un traitement ?", "url": "https://questionsmedicales.fr/mesh/D020765?mesh_terms=Gene+Expression+Regulation&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Artériopathies intracrâniennes", "description": "Quelles sont les complications possibles des artériopathies ?\nComment une artériopathie peut-elle mener à un AVC ?\nLes complications sont-elles réversibles ?\nQuel est l'impact des complications sur la qualité de vie ?\nComment surveiller les complications après un traitement ?", "url": "https://questionsmedicales.fr/mesh/D020765?mesh_terms=Gene+Expression+Regulation&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Artériopathies intracrâniennes", "description": "Quels sont les principaux facteurs de risque ?\nLe stress est-il un facteur de risque ?\nL'hérédité joue-t-elle un rôle ?\nComment l'âge influence-t-il le risque ?\nLes habitudes alimentaires influencent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D020765?mesh_terms=Gene+Expression+Regulation&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une artériopathie intracrânienne ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par imagerie cérébrale, comme l'IRM ou le scanner." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer le flux sanguin cérébral ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'échographie Doppler et l'angiographie sont couramment utilisés." } }, { "@type": "Question", "name": "Quels signes cliniques indiquent une artériopathie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des maux de tête, des vertiges ou des troubles neurologiques peuvent indiquer une pathologie." } }, { "@type": "Question", "name": "Quelle est l'importance des antécédents médicaux ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents de maladies cardiovasculaires aident à évaluer le risque d'artériopathie." } }, { "@type": "Question", "name": "Comment les tests sanguins aident-ils au diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Ils permettent d'évaluer les facteurs de risque comme le cholestérol et la glycémie." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des artériopathies intracrâniennes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des troubles de la vision et des vertiges." } }, { "@type": "Question", "name": "Comment reconnaître un AVC lié à une artériopathie ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme une faiblesse soudaine, des troubles de la parole ou des paralysies sont alarmants." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils varier selon l'âge ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent être plus subtils chez les personnes âgées." } }, { "@type": "Question", "name": "Les symptômes sont-ils toujours présents ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, certains patients peuvent être asymptomatiques malgré une artériopathie." } }, { "@type": "Question", "name": "Quels symptômes nécessitent une consultation urgente ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des maux de tête sévères ou des troubles neurologiques soudains nécessitent une urgence." } }, { "@type": "Question", "name": "Comment prévenir les artériopathies intracrâniennes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Adopter un mode de vie sain, contrôler la pression artérielle et éviter le tabac." } }, { "@type": "Question", "name": "Quel rôle joue l'alimentation dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée riche en fruits et légumes réduit le risque d'artériopathie." } }, { "@type": "Question", "name": "L'exercice physique est-il bénéfique ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier améliore la santé cardiovasculaire et réduit les risques." } }, { "@type": "Question", "name": "Comment le contrôle du stress aide-t-il ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Gérer le stress peut réduire les risques de maladies cardiovasculaires et d'artériopathies." } }, { "@type": "Question", "name": "Les bilans de santé réguliers sont-ils importants ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils permettent de détecter précocement les facteurs de risque et d'agir." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les artériopathies ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments anticoagulants et des interventions chirurgicales." } }, { "@type": "Question", "name": "Comment les médicaments aident-ils dans le traitement ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Ils aident à prévenir la formation de caillots et à améliorer le flux sanguin." } }, { "@type": "Question", "name": "Quand une intervention chirurgicale est-elle nécessaire ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Elle est nécessaire en cas de sténose sévère ou d'anévrisme menaçant." } }, { "@type": "Question", "name": "Les traitements sont-ils différents pour les jeunes et les vieux ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent varier en fonction de l'âge et des comorbidités." } }, { "@type": "Question", "name": "Quel rôle joue la rééducation après un traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La rééducation aide à récupérer les fonctions neurologiques et à améliorer la qualité de vie." } }, { "@type": "Question", "name": "Quelles sont les complications possibles des artériopathies ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent les AVC, les hémorragies cérébrales et les déficits neurologiques." } }, { "@type": "Question", "name": "Comment une artériopathie peut-elle mener à un AVC ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une obstruction ou une rupture d'artère peut provoquer un AVC ischémique ou hémorragique." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles, mais d'autres peuvent causer des séquelles." } }, { "@type": "Question", "name": "Quel est l'impact des complications sur la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent gravement affecter la qualité de vie et l'autonomie des patients." } }, { "@type": "Question", "name": "Comment surveiller les complications après un traitement ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des suivis réguliers et des examens d'imagerie sont essentiels pour surveiller l'évolution." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'hypertension, le diabète, le tabagisme et l'obésité." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut contribuer à l'augmentation des risques cardiovasculaires." } }, { "@type": "Question", "name": "L'hérédité joue-t-elle un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux d'artériopathies augmentent le risque individuel." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Le risque d'artériopathies augmente avec l'âge en raison de l'usure des vaisseaux sanguins." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en graisses saturées et en sucres augmente le risque." } } ] } ] }

Sources (10000 au total)

CFL1 restores the migratory capacity of bone marrow mesenchymal stem cells in primary Sjögren's syndrome by regulating CCR1 expression.

Primary Sjögren's syndrome (pSS) is a chronic systemic autoimmune disease. There is no relevant research on whether the migratory ability of bone marrow mesenchymal stem cells (BM-MSC) is impaired in ... Trajectories and velocities of BM-MSC were analyzed. Transwell migration assay and wound healing assay were used to investigate the migratory capacity of BM-MSC. The proliferative capacity of BM-MSC w... The migratory capacity of pSS-BMMSC was significantly reduced compared to normal volunteers (HC-BMMSC). The expression of the motility-related gene CFL1 was decreased in pSS-BMMSC. Lentivirus-mediated... The pSS-BMMSC leads to impaired migration and proliferation, and overexpression of CFL1 can rescue the functional deficiency and alleviate disease symptoms in NOD mice. Mechanically, CFL1 can regulate...

LncRNA-Anrel promotes the proliferation and migration of synovial fibroblasts through regulating miR-146a-mediated annexin A1 expression.

Increasing evidence demonstrates that long non-coding RNAs (lncRNAs) are closely related to multiple human autoimmune diseases, and their dysregulation is tightly linked to inflammation and disease pr... The lncRNAs expression profiles were interrogated with microarrays. The expressions of key lncRNAs were confirmed in synovial fibroblasts from RA patients and MH7A cells using qRT-PCR. Proliferations ... Nine lncRNAs were significantly altered in RA-SF, of which lncRNA-000239 showing the most significant upregulation. Overexpression of lncRNA-000239 significantly enhanced the proliferation and migrati... These data indicate that lncRNA-000239 upregulates annexin A1 expression via miR-146a and thus, promotes the proliferation and migration of RA-SF. This highlights a potential role of lncRNA-000239 as ...

SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression.

Spalt-like protein 4 (SALL4) is a stemness-related transcription factor whose abnormal re-expression contributes to cancer initiation and progression. However, the role of SALL4 in cancer angiogenesis... Analyses of clinical specimens via TCGA datasets were performed to determine the expression level and clinical significance of SALL4 in STAD (Stomach Adenocarcinoma). SALL4 knockdown, knockout, and ov... SALL4 expression was increased in STAD and positively correlated with tumor progression and poor prognosis. SALL4-B knockdown or knockout decreased while over-expression increased the promotion of hum... These findings suggest that SALL4 plays an important role in angiogenesis by transcriptionally regulating VEGF expression. Co-delivery of the functional siRNA and anticancer drug via exosomes represen...

Transcriptomic and co-expression network analyses on diverse wheat landraces identifies candidate master regulators of the response to early drought.

Over four billion people around the world rely on bread wheat (... Here, we utilized the YoGI landrace panel to identify 10,199 genes which were differentially expressed under early drought stress, before weighted gene co-expression network analysis (WGCNA) was used ... Of these hub genes, two stood out as novel candidate master regulators of the early drought response - one as an activator (... As well as appearing to coordinate the transcriptional early drought response, we propose that these hub genes may be able to regulate the physiological early drought response due to potential control...